Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs
- PMID: 15027860
- DOI: 10.1021/jm031029r
Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs
Abstract
An enzymatically activated liposome-based drug-delivery concept involving masked antitumor ether lipids (AELs) has been investigated. This concept takes advantage of the cytotoxic properties of AEL drugs as well as the membrane permeability enhancing properties of these molecules, which can lead to enhanced drug diffusion into cells. Three prodrugs of AELs (proAELs) have been synthesized and four liposome systems, consisting of these proAELs, were investigated for enzymatic degradation by secretory phospholipase A(2) (sPLA(2)), resulting in the release of AELs. The three synthesized proAELs were (R)-1-O-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine (1-O-DPPC), (R)-1-O-hexadecyl-2-palmitoyl-sn-glycero-3-phosphoethanolamine poly(ethylene glycol)(350) (1-O-DPPE-PEG(350)), and 1-O-DPPE-PEG(2000) of which 1-O-DPPC was the main liposome component. All three phospholipids were synthesized from the versatile starting material (R)-O-benzyl glycidol. A phosphorylation method, employing methyl dichlorophosphate, was developed and applied in the synthesis of two analogues of (R)-1-O-hexadecyl-2-palmitoyl-sn-glycero-3-phosphoethanolamine poly(ethylene glycol). Differential scanning calorimetry has been used to investigate the phase behavior of the lipid bilayers. A release study, employing calcein encapsulated in non-hydrolyzable 1,2-bis-O-octadecyl-sn-glycero-3-phosphocholine (D-O-SPC) liposomes, showed that proAELs, activated by sPLA(2), perturb membranes because of the detergent-like properties of the released hydrolysis products. A hemolysis investigation was conducted on human red blood cells, and the results demonstrate that proAEL liposomes display a very low hemotoxicity, which has been a major obstacle for using AELs in cancer therapy. The results suggest a possible way of combining a drug-delivery and prodrug concept in a single liposome system. Our investigation of the permeability-enhancing properties of the AEL molecules imply that by encapsulating conventional chemotherapeutic drugs, such as doxorubicin, in liposomes consisting of proAELs, an increased effect of the encapsulated drug might be achievable due to an enhanced transmembrane drug diffusion.
Similar articles
-
Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.Eur J Pharm Sci. 2012 Mar 12;45(4):408-20. doi: 10.1016/j.ejps.2011.09.013. Epub 2011 Sep 16. Eur J Pharm Sci. 2012. PMID: 21946258
-
Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.J Med Chem. 2005 Nov 17;48(23):7305-14. doi: 10.1021/jm049006f. J Med Chem. 2005. PMID: 16279790
-
Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.Biochimie. 2013 Nov;95(11):2018-33. doi: 10.1016/j.biochi.2013.07.006. Epub 2013 Jul 16. Biochimie. 2013. PMID: 23871914
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
-
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.Prog Lipid Res. 2005 Jan;44(1):68-97. doi: 10.1016/j.plipres.2004.12.001. Epub 2005 Jan 22. Prog Lipid Res. 2005. PMID: 15748655 Review.
Cited by
-
Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials.Mikrochim Acta. 2024 Aug 16;191(9):541. doi: 10.1007/s00604-024-06583-y. Mikrochim Acta. 2024. PMID: 39150483 Review.
-
Targeted Delivery Methods for Anticancer Drugs.Cancers (Basel). 2022 Jan 26;14(3):622. doi: 10.3390/cancers14030622. Cancers (Basel). 2022. PMID: 35158888 Free PMC article. Review.
-
Enzyme-polymeric/inorganic metal oxide/hybrid nanoparticle bio-conjugates in the development of therapeutic and biosensing platforms.J Adv Res. 2021 Feb 4;33:227-239. doi: 10.1016/j.jare.2021.01.012. eCollection 2021 Nov. J Adv Res. 2021. PMID: 34603792 Free PMC article. Review.
-
Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.Drug Deliv Transl Res. 2022 Jun;12(6):1293-1305. doi: 10.1007/s13346-021-01020-6. Epub 2021 Jul 12. Drug Deliv Transl Res. 2022. PMID: 34251612 Review.
-
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics.Int J Mol Sci. 2020 May 4;21(9):3248. doi: 10.3390/ijms21093248. Int J Mol Sci. 2020. PMID: 32375338 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous